✦ LIBER ✦

Salvage Bone Marrow Harvest in Patients Failing Plerixafor-Based Stem Cell Mobilization Attempt: Feasibility and Autologous Transplantation Outcomes

✍ Scribed by Kanate, Abraham S.; Watkins, Kathy; Cumpston, Aaron; Craig, Michael; Hamadani, Mehdi

Book ID: 120315259
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 208 KB
Volume: 19
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.04.019

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effectiveness and cost analysis of “just

Effectiveness and cost analysis of “just-in-time” salvage plerixafor administration in autologous transplant patients with poor stem cell mobilization kinetics

✍ Jie Li; Ellie Hamilton; Louette Vaughn; Michael Graiser; Heather Renfroe; Mary J 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 502 KB

144: Autologous stem cell transplantatio

144: Autologous stem cell transplantation (ASCT) for patients with multiple myeloma (MM): Impact of the degree of plasma cell bone marrow infiltration on mobilization kinetic and transplant outcomes

✍ A. Go; S.A. Gregory; P. Venugopal; J. Shammo; B. McLeod; H.C. Fung 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 72 KB

Autologous bone marrow mesenchymal stem

Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes

✍ Liang Peng; Dong-ying Xie; Bing-Liang Lin; Jing Liu; Hai-peng Zhu; Chan Xie; Yu- 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 603 KB

Our study aimed to investigate the short-term efficacy and long-term prognosis of liver failure patients caused by hepatitis B after a single transplantation with autologous marrow mesenchymal stem cells (MMSCs). A total of 527 inpatients with liver failure caused by hepatitis B were recruited and r

Autologous bone marrow mesenchymal stem

Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short-term and long-term outcomes

✍ Diarmaid D. Houlihan; Laurence J. Hopkins; Shankar X. Suresh; Matthew J. Armstro 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB

We read with interest the article titled ''Emergence of hepatitis B virus S gene mutants in patients experiencing HBsAg seroconversion after peginterferon therapy'' by Hsu and Yeh. 1 In this study, the authors found different substitutions within and outside the ''a'' determinant. They further teste

Plerixafor and Filgrastim XM02 (Tevagast

Plerixafor and Filgrastim XM02 (Tevagastrim®) as a first line peripheral blood stem cell mobilisation strategy in patients with multiple myeloma and lymphoma candidated to autologous bone marrow transplantation

✍ Giovanna Andreola; Aleksandra Babic; Cristina Rabascio; Mara Negri; Giovanni Mar 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Autologous peripheral blood stem cell tr

Autologous peripheral blood stem cell transplantation (Pbsct) In patients with lymphoma results in improved outcome and quality of life and cost reduction in comparison with bone marrow transplantation: The HOVON-22 study

✍ W.E. Fibbe; J.M. Raemaekers; L.F. Verdonck; P.J. Wijermans; R. van Oers; T. King 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 17 KB